GM
Global Medical REIT Inc.
GMRE-PA · NYSE
$24.63 -1.04% (-$0.26)
Market Cap $398.0M
P/E Ratio -
Div. Yield 7.61%
ROE 2.40%
Bulios Fair Price
$20.41
17.1% downside
Current Price
$24.63
Undervalued Fair Value Overvalued
According to Bulios Fair Price, GMRE-PA is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
92 /100
Cheap P/B 0.78x
P/FCF 21.36x
P/S 2.69x
Growth
100 /100
Growing Book val. growth 13.73%
Rev. growth 24.71%
FCF growth N/A
Profitability
53 /100
Moderate Net margin 8.18%
Op. margin 20.50%
FCF margin 12.57%
Quality
31 /100
Poor ROE 2.40%
ROA 0.98%
Asset turnover 0.12x
Debt
76 /100
Low Int. coverage 0.61x
Debt/Assets 0.00x
Debt/Equity 0.00x
Stability
53 /100
Moderate Rev. volatility 7.13%
EPS volatility 119.54%
Profitable years 4
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GMRE-PA
Online
Sector
Real Estate
Industry
REIT - Healthcare Facilities
CEO
Mark O. Decker Jr.
Employees
26
Headquarters
Bethesda